Streetbeat News

Analyst Ratings

ABM

UBS analyst Joshua Chan maintains a Neutral rating on ABM Industries (NYSE:ABM) but raises the price target from $51 to $55.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 2:06 pm

MMSI

Piper Sandler analyst Jason Bednar has reiterated an Overweight rating on Merit Medical Systems (NASDAQ:MMSI) and increased the price target from $100 to $110.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 2:04 pm

X

GLJ Research has upgraded United States Steel (NYSE:X) from Sell to Buy, setting a price target of $38.57.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 2:01 pm

EW

Edwards Lifesciences (NYSE:EW) received 19 analyst ratings over the past three months, with a mix of bullish and bearish perspectives. The average 12-month price target decreased by 15.39% to $83.32. Analysts have mostly lowered their price targets, reflecting cautious sentiment. Despite this, Edwards Lifesciences shows strong financial metrics, including a high net margin and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:01 pm

GMAB

Analysts have provided mixed ratings for Genmab (NASDAQ:GMAB) over the past three months, with a recent decrease in the average 12-month price target by 3.81%. Despite this, Genmab shows strong financial health with impressive revenue growth, net margin, ROE, and ROA, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

ADBE

Financial giants are showing a bullish interest in Adobe (NASDAQ:ADBE) through options trading, with a significant number of unusual trades detected. Analysts have set a price target range of $625 to $675, with a consensus target of $650. The stock is currently trading at $568.57, with an upcoming earnings announcement in 3 days.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

JHG

Analysts have provided mixed ratings for Janus Henderson Group (NYSE:JHG) over the past three months, with a recent increase in the average 12-month price target to $36.67. The company's financial performance shows strong revenue growth but challenges in profitability and return on equity.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

SMCI

Super Micro Computer (NASDAQ:SMCI) has seen a surge in options trading activity, with a significant number of calls and puts being traded. This suggests potential price movements, with investors eyeing a range from $365 to $800. Analysts have mixed ratings, with some downgrades and varied price targets.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

REGN

Over the past three months, 20 analysts have shared their evaluations of Regeneron Pharmaceuticals (NASDAQ:REGN), with a majority being somewhat bullish. The average 12-month price target has increased by 6.13% to $1199.6. Regeneron has shown strong financial performance with a high net margin and effective debt management.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

HZO

MarineMax (NYSE:HZO) has received a mix of bullish and bearish ratings from six analysts over the past three months. The average 12-month price target has increased by 10.48% to $42.17. Analysts have raised their price targets, reflecting positive sentiment and financial performance, including a 4.97% revenue growth rate and strong profitability metrics.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm